IP Library Granted Patent US 11,819,509
Granted Patent B2
US 11,819,509 · App. 17/116,418 · Granted Nov 21, 2023

Lipid compositions

Inventors: Finn Myhren (Oslo, NO); Nils Hoem (Oslo, NO); Asgeir Saebo (Eidsnes, NO); Anil R. Oroskar (Oak Brook, IL); Asha A. Oroskar (Oak Brook, IL); Anantha Krishna Mallia (Rockford, IL)
Assignee: Aker BioMarine Antarctic AS
A61K31/685A23K20/158A23K20/179A23K20/26A23L33/12A61K9/0053A61K31/20A61K31/215A61K31/23A61K31/683A61K35/612C11B3/006C11B3/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,819,509
App. No.
17/116,418
Granted
Nov 21, 2023
Kind
B2
Abstract

The present invention provides improved processes for extracting and preparing lipids from biological sources for use in pharmaceuticals, nutraceuticals and functional foods.

Claims (46)

1. A krill phospholipid composition comprising:

from 50% to 85% w/w phospholipids;

from 5% to 35% w/w triglycerides;

and wherein the composition further has the following properties:

the composition comprises from 2% w/w to 13% w/w free fatty acids;

the composition comprises less than 1.0% w/w inorganic salts; and

the composition comprises less than 10 ppm total arsenic.

2. The composition of claim 1 , wherein the composition further has one or more of the properties:

the composition comprises from 0.5% w/w to 10% w/w lysophospholipids;

the composition comprises from 0.01% to 1% w/w ethyl esters;

the composition is characterized in having a conductivity of less than 20 μS/cm when measured with 5% dry matter in 95% ethanol.

3. The composition of claim 1 , wherein the composition further has two or more of the following properties:

the composition comprises from 0.5% w/w to 10% w/w lysophospholipids;

the composition comprises from 0.01% to 1% w/w ethyl esters; and

the composition is characterized in having a conductivity of less than 20 μS/cm when measured with 5% dry matter in 95% ethanol.

4. The composition of claim 1 , wherein the composition has the following properties:

the composition comprises from 0.5% w/w to 10% w/w lysophospholipids;

the composition comprises from 0.01% to 1% w/w ethyl esters; and

the composition is characterized in having a conductivity of less than 20 μS/cm when measured with 5% dry matter in 95% ethanol.

5. The composition of claim 1 , further comprising a second nutraceutical ingredient.

6. The composition of claim 1 , further comprising a pharmaceutical carrier.

7. The composition of claim 1 , wherein the composition is provided in a delivery vehicle selected from the group consisting of an oral delivery vehicle, a functional food, a nutritional supplement, a dietary supplement and a medical food.

8. The composition of claim 7 , wherein said oral delivery vehicle is a soft gel capsule.

9. A krill phospholipid composition comprising:

from 30% to 50% w/w phospholipids;

from 32% to 52% w/w triglycerides;

and wherein the composition further has the following properties:

the composition comprises from 2% w/w to 13% w/w free fatty acids;

the composition comprises less than 1.0% w/w inorganic salts; and

the composition comprises less than 10 ppm total arsenic.

10. The composition of claim 9 , wherein the composition further has one or more of the properties:

the composition comprises from 0.5% w/w to 10% w/w lysophospholipids;

the composition comprises from 0.01% to 1% w/w ethyl esters;

the composition is characterized in having a conductivity of less than 20 μS/cm when measured with 5% dry matter in 95% ethanol.

11. The composition of claim 9 , wherein the composition further has two or more of the following properties:

the composition comprises from 0.5% w/w to 10% w/w lysophospholipids;

the composition comprises from 0.01% to 1% w/w ethyl esters; and

the composition is characterized in having a conductivity of less than 20 μS/cm when measured with 5% dry matter in 95% ethanol.

12. The composition of claim 9 , wherein the composition has the following properties:

the composition comprises from 0.5% w/w to 10% w/w lysophospholipids;

the composition comprises from 0.01% to 1% w/w ethyl esters; and

the composition is characterized in having a conductivity of less than 20 μS/cm when measured with 5% dry matter in 95% ethanol.

13. The composition of claim 9 , further comprising a second nutraceutical ingredient.

14. The composition of claim 9 , further comprising a pharmaceutical carrier.

15. The composition of claim 9 , wherein the composition is provided in a delivery vehicle selected from the group consisting of an oral delivery vehicle, a functional food, a nutritional supplement, a dietary supplement and a medical food.

16. The composition of claim 15 , wherein said oral delivery vehicle is a soft gel capsule.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2024
From: AKER BIOMARINE ANTARCTIC AS
To: AKER BIOMARINE HUMAN INGREDIENTS AS
Reel/Frame 066703/0864 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2021
From: MYHREN, FINN; HOEM, NILS; SAEBO, ASGEIR; OROSKAR, ANIL R.; OROSKAR, ASHA A.; MALLIA, ANANTHA KRISHNA
To: AKER BIOMARINE ANTARCTIC AS
Reel/Frame 055175/0529 →
Continuity (3)
Continuation 15040347 · Feb 10, 2016
Provisional Application 62114811 · Feb 11, 2015
Related Publication 20210085698A1 · Mar 25, 2021